Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2008 5
2009 8
2010 5
2011 6
2012 10
2013 9
2014 6
2015 7
2016 11
2017 12
2018 20
2019 23
2020 20
2021 20
2022 20
2023 20
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Smouldering multiple sclerosis: the 'real MS'.
Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobaeus E, Jensen MB, García-Domínguez JM, Sousa L, De Rossi N, Hupperts R, Fenu G, Bodini B, Kuusisto HM, Stankoff B, Lycke J, Airas L, Granziera C, Scalfari A. Giovannoni G, et al. Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. doi: 10.1177/17562864211066751. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35096143 Free PMC article. Review.
We hypothesise that therapeutically targeting a state of 'no evident inflammatory disease activity' (NEIDA) cannot sufficiently prevent disability accumulation in MS, meaning that treatment should also focus on other brain and spinal cord pathological processes contributin …
We hypothesise that therapeutically targeting a state of 'no evident inflammatory disease activity' (NEIDA) cannot sufficiently prevent disa …
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
Imaging in neuro-oncology.
Nandu H, Wen PY, Huang RY. Nandu H, et al. Ther Adv Neurol Disord. 2018 Feb 28;11:1756286418759865. doi: 10.1177/1756286418759865. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29511385 Free PMC article. Review.
Imaging plays several key roles in managing brain tumors, including diagnosis, prognosis, and treatment response assessment. Ongoing challenges remain as new therapies emerge and there are urgent needs to find accurate and clinically feasible methods to noninvasively evalu …
Imaging plays several key roles in managing brain tumors, including diagnosis, prognosis, and treatment response assessment. Ongoing …
New developments in brain metastases.
Berghoff AS, Preusser M. Berghoff AS, et al. Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418785502. doi: 10.1177/1756286418785502. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30034538 Free PMC article. Review.
Patients with brain metastases (BM) are a population of high clinical need for new therapeutic approaches due to, as yet, very impaired survival prognosis. ...New developments in the treatment of BM patients aim to reduce the side effects of local therapies, for example, b …
Patients with brain metastases (BM) are a population of high clinical need for new therapeutic approaches due to, as yet, very impair …
The potential of lasmiditan in migraine.
Mecklenburg J, Raffaelli B, Neeb L, Sanchez Del Rio M, Reuter U. Mecklenburg J, et al. Ther Adv Neurol Disord. 2020 Oct 21;13:1756286420967847. doi: 10.1177/1756286420967847. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33403005 Free PMC article. Review.
Treatment-related side effects seem to be related to the rapid penetration of the drug into the brain and include dizziness, paresthesia and drowsiness, mostly of mild to moderate intensity. ...
Treatment-related side effects seem to be related to the rapid penetration of the drug into the brain and include dizziness, paresthe …
Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson's disease: a randomized controlled study comparing three exercise models.
Schaible F, Maier F, Buchwitz TM, Schwartz F, Hoock M, Schönau E, Libuda M, Hordt A, van Eimeren T, Timmermann L, Eggers C. Schaible F, et al. Ther Adv Neurol Disord. 2021 Feb 18;14:1756286420986744. doi: 10.1177/1756286420986744. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33680093 Free PMC article.
Advances in brain imaging in multiple sclerosis.
Cortese R, Collorone S, Ciccarelli O, Toosy AT. Cortese R, et al. Ther Adv Neurol Disord. 2019 Jun 27;12:1756286419859722. doi: 10.1177/1756286419859722. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31275430 Free PMC article. Review.
Brain imaging is increasingly used to support clinicians in diagnosing multiple sclerosis (MS) and monitoring its progression. ...Similarly, MRI markers of neurodegeneration exhibit the potential as primary and secondary outcomes in clinical trials for progressive phenotyp
Brain imaging is increasingly used to support clinicians in diagnosing multiple sclerosis (MS) and monitoring its progression. ...Sim
Advances in imaging of brain abnormalities in neuromuscular disease.
Angelini C, Pinzan E. Angelini C, et al. Ther Adv Neurol Disord. 2019 May 6;12:1756286419845567. doi: 10.1177/1756286419845567. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31105770 Free PMC article. Review.
Brain atrophy, white matter abnormalities, and ventricular enlargement have been described in different neuromuscular diseases (NMDs). ...Pathological brain changes with cognitive dysfunction seemed to be frequently associated in NMDs. ...
Brain atrophy, white matter abnormalities, and ventricular enlargement have been described in different neuromuscular diseases (NMDs)
Epigenetic regulation of inflammation in stroke.
Ng GY, Lim YA, Sobey CG, Dheen T, Fann DY, Arumugam TV. Ng GY, et al. Ther Adv Neurol Disord. 2018 Apr 26;11:1756286418771815. doi: 10.1177/1756286418771815. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29774056 Free PMC article. Review.
A plethora of inflammatory events occur during stroke, arising in part due to the body's immune response to brain injury. Neuroinflammation contributes significantly to neuronal cell death and the development of functional impairment and death in stroke patients. ...Epigen …
A plethora of inflammatory events occur during stroke, arising in part due to the body's immune response to brain injury. Neuroinflam …
207 results